K. Nieto

发表

AAV Vectors Vaccines Against Infectious Diseases

A. Salvetti, K. Nieto, Karen Nieto, 2014, Front. Immunol..

Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate

R. Roden, J. Kleinschmidt, B. Karanam, 2012, PloS one.

Properties of the Adeno-Associated Virus Assembly-Activating Protein

Norman E. Davey, N. Davey, J. Kleinschmidt, 2012, Journal of Virology.

Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaques.

J. Kleinschmidt, B. Leuchs, L. Gissmann, 2012, Human gene therapy.

Trans-spliced peptides spanning PDGFRα and Adeno- Associated Virus type 5 trigger autoimmune responses in systemic sclerosis patients

A. Gabrielli, M. Galgani, K. Nieto, 2022 .

Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors

J. Kleinschmidt, B. Leuchs, L. Gissmann, 2009, Antiviral therapy.

The therapeutic vaccine: is it feasible?

L. Gissmann, K. Nieto, Karen Nieto, 2009, Archives of medical research.

Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques

R. Steinman, K. Überla, P. Rácz, 2009, PLoS pathogens.

HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation

E. Garrido, M. Salcedo, K. Nieto, 2011, Virology Journal.

Transformation by high-risk HPV is the consequence of persistent infections

L. Gissmann, K. Nieto, Lysann Schädlich, 2010 .

The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes

B. Böttcher, J. Kleinschmidt, C. Raupp, 2011, Journal of Virology.

Human Papillomavirus-Specific Immune Therapy: Failure and Hope

L. Gissmann, K. Nieto, Lysann Schädlich, 2010, Antiviral therapy.